PHENDIMETRAZINE TARTRATE

N/A

Manufactured by Acertis Pharmaceuticals, LLC

196 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PHENDIMETRAZINE TARTRATE

PHENDIMETRAZINE TARTRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Acertis Pharmaceuticals, LLC. The most commonly reported adverse reactions for PHENDIMETRAZINE TARTRATE include DRUG INEFFECTIVE, PAIN, HEADACHE, WEIGHT INCREASED, BACK PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PHENDIMETRAZINE TARTRATE.

Top Adverse Reactions

DRUG INEFFECTIVE9 reports
PAIN7 reports
HEADACHE6 reports
WEIGHT INCREASED6 reports
BACK PAIN5 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS5 reports
CHOROIDAL EFFUSION4 reports
DYSPNOEA4 reports
FATIGUE4 reports
MYOPIA4 reports
OCULAR HYPERTENSION4 reports
OFF LABEL USE4 reports
ARTHRALGIA3 reports
FALL3 reports
HUNGER3 reports
HYPOAESTHESIA3 reports
MALAISE3 reports
NECK PAIN3 reports
PAIN IN EXTREMITY3 reports
PARAESTHESIA3 reports
PRURITUS3 reports
ASTHENIA2 reports
CHILLS2 reports
COVID 192 reports
DRUG EFFECT DECREASED2 reports
DRY MOUTH2 reports
ERYTHEMA2 reports
FLUSHING2 reports
FOOD CRAVING2 reports
HYPERSENSITIVITY2 reports
HYPERTENSION2 reports
INCORRECT DOSE ADMINISTERED2 reports
INFLUENZA2 reports
INJECTION SITE PAIN2 reports
INTERVERTEBRAL DISC PROTRUSION2 reports
MENSTRUAL DISORDER2 reports
MULTIPLE ALLERGIES2 reports
MUSCLE SPASMS2 reports
NASOPHARYNGITIS2 reports
NAUSEA2 reports
OSTEOPOROSIS2 reports
PRODUCT USE ISSUE2 reports
PYREXIA2 reports
RECTAL HAEMORRHAGE2 reports
RESPIRATORY DISORDER2 reports
SEASONAL ALLERGY2 reports
SINUSITIS2 reports
UPPER RESPIRATORY TRACT INFECTION2 reports
WEIGHT DECREASED2 reports
ABDOMINAL PAIN1 reports
ABDOMINAL PAIN UPPER1 reports
ABNORMAL SLEEP RELATED EVENT1 reports
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD1 reports
ADVERSE EVENT1 reports
ASTHENOPIA1 reports
BLINDNESS1 reports
BLOOD GLUCOSE DECREASED1 reports
BONE DEMINERALISATION1 reports
BRAIN INJURY1 reports
BREAST PAIN1 reports
CARDIAC ARREST1 reports
CATARACT1 reports
CEREBROVASCULAR ACCIDENT1 reports
CHEST DISCOMFORT1 reports
CHEST PAIN1 reports
CHOLECYSTECTOMY1 reports
CHRONIC KIDNEY DISEASE1 reports
COGNITIVE DISORDER1 reports
COLITIS1 reports
CONCUSSION1 reports
CONDITION AGGRAVATED1 reports
CONSTIPATION1 reports
CONTUSION1 reports
CORONARY ARTERY DISEASE1 reports
COVID 19 PNEUMONIA1 reports
CYSTITIS1 reports
DECREASED APPETITE1 reports
DECREASED INTEREST1 reports
DEEP VEIN THROMBOSIS1 reports
DEPRESSED MOOD1 reports
DEVICE ISSUE1 reports
DIARRHOEA1 reports
DIZZINESS1 reports
DRUG DEPENDENCE1 reports
DRUG HYPERSENSITIVITY1 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION1 reports
DRY EYE1 reports
ELECTROCARDIOGRAM T WAVE INVERSION1 reports
EMOTIONAL DISTRESS1 reports
EYE DISCHARGE1 reports
EYE IRRITATION1 reports
EYE PAIN1 reports
FEELING ABNORMAL1 reports
FLATULENCE1 reports
FOOT OPERATION1 reports
FREQUENT BOWEL MOVEMENTS1 reports
GENERALISED OEDEMA1 reports
GLUCOSE TOLERANCE IMPAIRED1 reports
HAEMATOCHEZIA1 reports
HEAD INJURY1 reports

Report Outcomes

Out of 57 classified reports for PHENDIMETRAZINE TARTRATE:

Serious 38.6%Non-Serious 61.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female42 (82.4%)
Male9 (17.6%)

Reports by Age

Age 252 reports
Age 272 reports
Age 322 reports
Age 392 reports
Age 492 reports
Age 532 reports
Age 602 reports
Age 642 reports
Age 301 reports
Age 341 reports
Age 351 reports
Age 411 reports
Age 451 reports
Age 471 reports
Age 541 reports
Age 551 reports
Age 581 reports
Age 591 reports
Age 611 reports
Age 661 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PHENDIMETRAZINE TARTRATE?

This profile reflects 196 FDA FAERS reports that mention PHENDIMETRAZINE TARTRATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PHENDIMETRAZINE TARTRATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, PAIN, HEADACHE, WEIGHT INCREASED, BACK PAIN, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PHENDIMETRAZINE TARTRATE?

Labeling and FAERS entries often list Acertis Pharmaceuticals, LLC in connection with PHENDIMETRAZINE TARTRATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.